-
Publications
-
Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies
Joshi G, Natarajan N, Dickerson KE, Voit RA British Journal of Haematology 2026 -
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias
Fleming TJ, Antoszewski M, Lambo S, Gundry MC, Piussi R, Wahlster L, Shah S, Reed FE, Dong KD, Paulo JA, Gygi SP, Mimoso C, Goldman SR, Adelman K, Perry JA, Pikman Y, Stegmaier K, Barrachina MN, Machlus KR, Hovestadt V, Arruda A, Minden MD, Voit RA, Sankaran VG Blood 2025 Dec 146 3019-3035 -
Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia
Voit RA, Liao X, Caulier A, Antoszewski M, Cohen B, Armant M, Lu HY, Fleming TJ, Kamal E, Wahlster L, Roche AM, Everett JK, Petrichenko A, Huang MM, Clarke W, Myers KC, Forester C, Perez-Atayde A, Bushman FD, Pellin D, Shimamura A, Williams DA, Sankaran VG Cell Stem Cell 2025 Jan 32 38-52.e6 -
Gene therapy for congenital marrow failure syndromes – no longer grasping at straws?
Voit RA, Corey SJ Haematologica 2023 Nov 108 2880-2882 -
MECOM Deficiency: from Bone Marrow Failure to Impaired B-Cell Development
Voit RA, Sankaran VG Journal of Clinical Immunology 2023 Aug 43 1052-1066 -
CD11c regulates neutrophil maturation
Hou L, Voit RA, Shibamura-Fujiogi M, Koutsogiannaki S, Li Y, Chen Y, Luo H, Sankaran VG, Yuki K Blood Advances 2023 Apr 7 1312-1325 -
A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia
Voit RA, Tao L, Yu F, Cato LD, Cohen B, Fleming TJ, Antoszewski M, Liao X, Fiorini C, Nandakumar SK, Wahlster L, Teichert K, Regev A, Sankaran VG Nature immunology 2023 Jan 24 69-83 -
Multi-omics on our multitudes
Voit RA, Sankaran VG Nature genetics 2022 Oct 54 1449-1450 -
A unified model of human hemoglobin switching through single-cell genome editing
Shen Y, Verboon JM, Zhang Y, Liu N, Kim YJ, Marglous S, Nandakumar SK, Voit RA, Fiorini C, Ejaz A, Basak A, Orkin SH, Xu J, Sankaran VG Nature communications 2021 Dec 12 -
Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing
Shen Y, Li R, Teichert K, Montbleau KE, Verboon JM, Voit RA, Sankaran VG PLoS genetics 2021 Oct 17 -
Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript
Wahlster L, Verboon JM, Ludwig LS, Black SC, Luo W, Garg K, Voit RA, Collins RL, Garimella K, Costello M, Chao KR, Goodrich JK, DiTroia SP, O’Donnell-Luria A, Talkowski ME, Michelson AD, Cantor AB, Sankaran VG Journal of Experimental Medicine 2021 Apr 218 -
CD11c regulates hematopoietic stem and progenitor cells under stress
Hou L, Voit RA, Sankaran VG, Springer TA, Yuki K Blood Advances 2020 Dec 4 6086-6097 -
Sowing the Seeds of Clonal Hematopoiesis
Liggett LA, Voit RA, Sankaran VG Cell Stem Cell 2020 Aug 27 195-197 -
Pyruvate kinase deficiency in a newborn with extramedullary hematopoiesis in the skin
Voit RA, Grace RF Blood 2020 Aug 136 770 -
Stabilizing HIF to Ameliorate Anemia
Voit RA, Sankaran VG Cell 2020 Jan 180 6 -
SAPTA: A new design tool for improving TALE nuclease activity
Lin Y, Fine EJ, Zheng Z, Antico CJ, Voit RA, Porteus MH, Cradick TJ, Bao G Nucleic acids research 2014 Apr 42 e47 -
Nuclease-mediated gene editing by homologous recombination of the human globin locus
Voit RA, Hendel A, Pruett-Miller SM, Porteus MH Nucleic acids research 2014 Jan 42 1365-1378 -
Generation of an HIV resistant T-cell line by targeted "stacking" of restriction factors
Voit RA, McMahon MA, Sawyer SL, Porteus MH Molecular Therapy 2013 Apr 21 786-795 -
Nuclease mediated targeted genome modification in mammalian cells
Barker JC, Voit RA, Porteus MH 2013 327-352 -
An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level
Bauer DE, Kamran SC, Lessard S, Xu J, Fujiwara Y, Lin C, Shao Z, Canver MC, Smith EC, Pinello L, Sabo PJ, Vierstra J, Voit RA, Yuan GC, Porteus MH, Stamatoyannopoulos JA, Lettre G, Orkin SH Science 2013 342 253-257
-
Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies
Richard Voit, M.D., Ph.D.
- Horchow Family Scholar in Pediatrics
- Pediatrics - Hematology-Oncology
Education & Training
- Residency - Boston Children's Hospital (2014-2017), Pediatrics
- Medical Education - UT Southwestern Medical School (2006-2014), Doctor of Medicine/Doctor of Philosophy
- Fellowship - Boston Children's Hospital (2017-2020), Pediatric Hematology/Oncology